Pharmapack Stade

Pharmapack Stade

Stade, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Pharmapack Stade is a well-established, private German contract development and manufacturing organization (CDMO) focused exclusively on secondary packaging services, primarily blistering. The company operates as a specialized service provider within the pharmaceutical and healthcare supply chain, emphasizing quality, flexibility, and customer proximity. Its business model is based on providing outsourced packaging services to pharmaceutical and nutraceutical companies, generating revenue through service fees. While not a drug developer itself, Pharmapack Stade plays a critical role in the final manufacturing steps before products reach the market.

Drug DeliveryMedical Devices

Technology Platform

Industrial blister packaging and serialization machinery operated under GMP standards, providing unit-dose and secondary packaging as a service.

Opportunities

Growth is driven by the pharmaceutical industry's ongoing outsourcing trend, stringent serialization regulations requiring specialized investment, and expansion in the nutraceutical sector.
The company's flexibility for both small and large batch sizes positions it well for niche therapies and variable demand.

Risk Factors

Key risks include customer concentration, intense price competition in the contract packaging market, and the ever-present regulatory and quality compliance risk inherent in GMP operations.
Supply chain volatility for packaging materials also poses a margin pressure risk.

Competitive Landscape

Pharmapack Stade competes in the fragmented pharmaceutical contract packaging market against large multinational CDMOs (e.g., Catalent, Recipharm) and numerous smaller regional specialists. Its differentiation is based on mid-sized flexibility, customer proximity, and a quality-focused reputation within the German and European market.